CAS RN: 13845-18-6

Sodium Sulfamate

Product Availability

Choose a grade to view its available package options.

4 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250613 100g In stock Shanghai, Shenzhen, Tianjin, Wuhan Inquiry
Batchno.20250303 1kg In stock Shanghai, Tianjin Inquiry
Batchno.20250306 25g In stock Shanghai, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250827 500g In stock Shanghai, Shenzhen Inquiry
  • Product code: SSC-048456
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 500g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 13845-18-6
Pack Size Recorded Purity Available Qty Ship From Inquiry
500g ≥97% 0 Out of Stock Hong Kong Inquiry

13845-18-6 / sodium sulfamate

Standard CAS: 13845-18-6 Multi CAS: No

Basic Information

CAS
13845-18-6
Multi CAS
No
Molecular Formula
H2NNaO3S
Molecular Weight
119.080000
Exact Mass
118.965308
SMILES
NS(=O)(=O)[O-].[Na+]
InChI
InChI=1S/H3NO3S.Na/c1-5(2,3)4;/h(H3,1,2,3,4);/q;+1/p-1
InChIKey
QDWYPRSFEZRKDK-UHFFFAOYSA-M

Physical Properties

Physical Description
Dry Powder; Liquid Hygroscopic solid
State
Solid

Computed Properties

Structural Parameters

Heavy atom count
6
H-bond acceptors
3
H-bond donors
1
Molar refractivity
13.88
TPSA
83.22

LogP / Solubility

WLOGP
-4.59
MLOGP
-4.05
XLogP3
-4.59
Consensus LogP
-4.41
Log S (ESOL)
2.31
Class (ESOL)
Highly soluble
Log S (Ali)
2.78
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
3.38
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.71

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 119 of 120 companies (only 0.8% companies provided GHS information). For more detailed information, please visit ECHA C&L website. Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us